Perspectives on Treatment Burden for Methotrexate and Tumor Necrosis Factor Inhibitors Among Patients With Psoriatic Arthritis and Rheumatoid Arthritis: A Qualitative Study

Perspectives on Treatment Burden for Methotrexate and Tumor Necrosis Factor Inhibitors Among Patients With Psoriatic Arthritis and Rheumatoid Arthritis: A Qualitative Study

Objective To describe patients’ perspectives on the burden associated with methotrexate (MTX) or tumor necrosis factor inhibitor (TNFi) use in psoriatic arthritis (PsA) and rheumatoid arthritis (RA). Methods Between May 2019 and March 2020, patients receiving MTX and/or a TNFi for either PsA or RA w...

Full description

Bibliographic Details
Main Authors: Alexis Ogdie, Yomei Shaw, Michele Almonte, Ervant J. Maksabedian Hernandez, Bradley Stolshek, Kaleb Michaud
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:ACR Open Rheumatology
Online Access:https://doi.org/10.1002/acr2.11530

Internet

https://doi.org/10.1002/acr2.11530

Similar Items